[go: up one dir, main page]

MA42973A - MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS - Google Patents

MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS

Info

Publication number
MA42973A
MA42973A MA042973A MA42973A MA42973A MA 42973 A MA42973 A MA 42973A MA 042973 A MA042973 A MA 042973A MA 42973 A MA42973 A MA 42973A MA 42973 A MA42973 A MA 42973A
Authority
MA
Morocco
Prior art keywords
hyperimmunity
personalized
psoriasis
manufacture
treatment
Prior art date
Application number
MA042973A
Other languages
French (fr)
Inventor
Chiurciu Constantin
Victor Patrascu Ionel
Iuliana Mihai
Lucica Sima
Chiurciu Viorica
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA42973A publication Critical patent/MA42973A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA042973A 2015-10-16 2016-01-08 MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS MA42973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (en) 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment

Publications (1)

Publication Number Publication Date
MA42973A true MA42973A (en) 2018-08-22

Family

ID=55754390

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042973A MA42973A (en) 2015-10-16 2016-01-08 MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS

Country Status (4)

Country Link
EP (1) EP3362092A1 (en)
MA (1) MA42973A (en)
RO (1) RO130965A8 (en)
WO (1) WO2017065626A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (en) 2017-06-06 2018-12-28 Fântână Raul Sorin Composition and method for preparing and evaluating a complex immunogen named i-spga meant to produce immunologically active proteins
US11319382B1 (en) 2021-06-28 2022-05-03 King Abdulaziz University Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068524C (en) * 1997-06-23 2001-07-18 叶庆炜 Process for preparing medicine for curing intractable psoriasis
JP2002509109A (en) * 1998-01-19 2002-03-26 ディーシーヴィー インコーポレイテッド Compositions and methods for treating and preventing arthritis and / or autoimmune diseases
IL143027A0 (en) * 1998-11-16 2002-04-21 Genway Biotech Inc Generation of antibodies using polynucleotide vaccination in avian species
WO2008025099A1 (en) * 2006-08-31 2008-03-06 A.C.N. 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions
US20100233162A1 (en) * 2007-08-30 2010-09-16 Bengt Agerup LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
JP5439127B2 (en) * 2009-11-13 2014-03-12 株式会社さいわいメディカル Treatment for psoriasis or atopic dermatitis
RO129645B1 (en) * 2014-02-25 2022-05-30 Romvac Company S.A. Process for obtaining and using hen immunoglobulins (igy)
RO130213A8 (en) * 2014-10-29 2017-06-30 Romvac Company S.A. Production and use of hyperimmune egg - pc2

Also Published As

Publication number Publication date
RO130965A8 (en) 2017-06-30
EP3362092A1 (en) 2018-08-22
RO130965A0 (en) 2016-03-30
WO2017065626A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
IL279752A (en) Polycyclic compounds and their use in the treatment of immune disorders
IL283086A (en) Use of cannabidiol in the treatment of multiple sclerosis complex
DK3641819T3 (en) USE OF CANNABIDIOL IN TREATMENT OF TUBEOUS SCLEROSIS COMPLEX
HUE054548T2 (en) Aminotriazolopyridine compounds and their use in the treatment of cancer
EP3359171C0 (en) USE OF AKKERMANSIA MUCINIPHILA IN THE TREATMENT OF INFLAMMATORY DISEASES
SI3240554T1 (en) Blautia stercosis and wexlerae for use in the treatment of inflammatory and autoimmune diseases
MA45192A (en) ASSOCIATION TREATMENT
HUE051476T2 (en) Use of cannabidiol acid in the treatment of epilepsy
EP3393475C0 (en) CIFORADENT ALONE OR IN COMBINATION WITH ATÉZOLIZUMAB FOR USE IN THE TREATMENT OF CANCER
MA39960A (en) IMIDAZO [4,5C] QUINOLINE-2-ONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
PL3512517T3 (en) USE OF PRIDOPIDINE IN THE TREATMENT OF ANXIETY AND DEPRESSION
EP3653630A4 (en) THIAMIDINOAMIDE-ENDOCYCLIC ARYLAMIDE COMPOUND AND ITS USE IN THE TREATMENT OF HEPATITIS B
DK3313401T3 (en) NANOPARTICLES INCLUDING SIROLIMUS AND ALBUMIN FOR USE IN THE TREATMENT OF EPITHELIOID CELL TUMORS
HUE055635T2 (en) Use of probiotics in the treatment and / or prevention of psoriasis
PL3503890T3 (en) USE OF PRIDOPIDINE IN THE TREATMENT OF DYSTONIA
EP2983619A4 (en) SURGICAL ORIENTATION AND PLANNING SOFTWARE FOR THE TREATMENT OF ASTIGMATISM
DK3442513T3 (en) USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS
EP3503903A4 (en) ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
IL287704A (en) Use of cannabidiol in the treatment of multiple sclerosis complex
MA47450A (en) SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
EP3397063A4 (en) USE OF MICROBULLES AND NANOBULLES IN THE TREATMENT OF LIQUID
EP3848022C0 (en) THERAPEUTIC AGENT FOR USE IN THE TREATMENT OF INFECTIONS
DK3551166T3 (en) TOPICAL PHENYTOIN FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
EP2969001A4 (en) USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
EP3337784A4 (en) USE OF UREIDOMUSTIN (BO-1055) IN THE TREATMENT OF CANCER